All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2

作者: M Labussiere , A Idbaih , X-W Wang , Y Marie , B Boisselier

DOI: 10.1212/WNL.0B013E3181E1CF3A

关键词:

摘要: Background: Recently, the gene encoding human cytosolic NADPH-dependent isocitrate dehydrogenase ( IDH1 ) was reported frequently mutated in gliomas. Rare mutations were also found sequence of mitochondrial isoform IDH2 . Methods: In a series 764 gliomas genome-wide characterized, we determined presence sequences both and genes by direct sequencing. Results: We that all tumors with complete 1p19q codeletion (n = 128) (118) or (10) gene. This 100% mutation rate contrasted strikingly other exhibiting either variable 1p 19q alterations 159, IDH1/IDH2 33%) no alteration 477, 32%). Our data confirm prognostic impact whatever grade considered: patients harboring have an improved median overall survival. Moreover, WHO II III gliomas, 3 groups significantly different outcomes identified according to their statuses. Tumors carrying had longer survival than nonmutated counterpart. Conclusions: exclusive association suggests new mechanism tumorigenesis. Perhaps is prerequisite for occurrence t(1;19) translocation, it required codeleted cells acquire tumor phenotype.

参考文章(15)
Yang Shi, Johnathan R. Whetstine, Dynamic regulation of histone lysine methylation by demethylases. Molecular Cell. ,vol. 25, pp. 1- 14 ,(2007) , 10.1016/J.MOLCEL.2006.12.010
Bernhard Lehnertz, Yoshihide Ueda, Alwin A.H.A. Derijck, Ulrich Braunschweig, Laura Perez-Burgos, Stefan Kubicek, Taiping Chen, En Li, Thomas Jenuwein, Antoine H.F.M. Peters, Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin Current Biology. ,vol. 13, pp. 1192- 1200 ,(2003) , 10.1016/S0960-9822(03)00432-9
J. Gregory Cairncross, Keisuke Ueki, Magdelena C. Zlatescu, David K. Lisle, Dianne M. Finkelstein, Robert R. Hammond, Jonathan S. Silver, Paul C. Stark, David R. Macdonald, Yasushi Ino, David A. Ramsay, David N. Louis, Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas Journal of the National Cancer Institute. ,vol. 90, pp. 1473- 1479 ,(1998) , 10.1093/JNCI/90.19.1473
D. W. Parsons, S. Jones, X. Zhang, J. C.-H. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, I-M. Siu, G. L. Gallia, A. Olivi, R. McLendon, B. A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. A. Busam, H. Tekleab, L. A. Diaz, J. Hartigan, D. R. Smith, R. L. Strausberg, S. K. N. Marie, S. M. O. Shinjo, H. Yan, G. J. Riggins, D. D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu, K. W. Kinzler, An Integrated Genomic Analysis of Human Glioblastoma Multiforme Science. ,vol. 321, pp. 1807- 1812 ,(2008) , 10.1126/SCIENCE.1164382
François Ducray, Ahmed Idbaih, Aurélien de Reyniès, Ivan Bièche, Joëlle Thillet, Karima Mokhtari, Séverine Lair, Yannick Marie, Sophie Paris, Michel Vidaud, Khê Hoang-Xuan, Olivier Delattre, Jean-Yves Delattre, Marc Sanson, None, Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile Molecular Cancer. ,vol. 7, pp. 41- 41 ,(2008) , 10.1186/1476-4598-7-41
Christoph Loenarz, Christopher J Schofield, Expanding chemical biology of 2-oxoglutarate oxygenases Nature Chemical Biology. ,vol. 4, pp. 152- 156 ,(2008) , 10.1038/NCHEMBIO0308-152
Lenny Dang, David W. White, Stefan Gross, Bryson D. Bennett, Mark A. Bittinger, Edward M. Driggers, Valeria R. Fantin, Hyun Gyung Jang, Shengfang Jin, Marie C. Keenan, Kevin M. Marks, Robert M. Prins, Patrick S. Ward, Katharine E. Yen, Linda M. Liau, Joshua D. Rabinowitz, Lewis C. Cantley, Craig B. Thompson, Matthew G. Vander Heiden, Shinsan M. Su, Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature. ,vol. 462, pp. 739- 744 ,(2009) , 10.1038/NATURE08617
Ahmed Idbaih, Yannick Marie, Carlo Lucchesi, Gaëlle Pierron, Elodie Manié, Virginie Raynal, Véronique Mosseri, Khê Hoang-Xuan, Michèle Kujas, Isabel Brito, Karima Mokhtari, Marc Sanson, Emmanuel Barillot, Alain Aurias, Jean-Yves Delattre, Olivier Delattre, BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas International Journal of Cancer. ,vol. 122, pp. 1778- 1786 ,(2007) , 10.1002/IJC.23270
Magdalena Benetkiewicz, Ahmed Idbaih, Pierre-Yves Cousin, Blandine Boisselier, Yannick Marie, Emmanuelle Criniere, Kheˆ Hoang-Xuan, Jean-Yves Delattre, Marc Sanson, Olivier Delattre, None, NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas PLoS ONE. ,vol. 4, pp. e4107- ,(2009) , 10.1371/JOURNAL.PONE.0004107
Robert B. Jenkins, Hilary Blair, Karla V. Ballman, Caterina Giannini, Robert M. Arusell, Mark Law, Heather Flynn, Sandra Passe, Sara Felten, Paul D. Brown, Edward G. Shaw, Jan C. Buckner, A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma Cancer Research. ,vol. 66, pp. 9852- 9861 ,(2006) , 10.1158/0008-5472.CAN-06-1796